Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126435181 | 12643518 | 1 | I | 20160714 | 20160727 | 20160811 | 20160811 | EXP | LM20160752 | FR-VALIDUS PHARMACEUTICALS LLC-FR-2016VAL002402 | VALIDUS | 65.00 | YR | M | Y | 0.00000 | 20160811 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126435181 | 12643518 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MILLIGRAM(S); DAILY | N | UNKNOWN | 16273 | 20 | MG | ||||||
| 126435181 | 12643518 | 2 | SS | TERCIAN /00759301/ | CYAMEMAZINE | 1 | Oral | 1 DOSAGE FORM; DAILY | U | UNKNOWN | 0 | 1 | DF | FILM-COATED TABLET | |||||
| 126435181 | 12643518 | 3 | SS | TRAMADOL. | TRAMADOL | 1 | Oral | 50 MILLIGRAM(S); 3 TIMES A DAY | U | UNKNOWN | 0 | 50 | MG | ||||||
| 126435181 | 12643518 | 4 | SS | KARDEGIC | ASPIRIN LYSINE | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 126435181 | 12643518 | 5 | SS | GARDENAL /00023201/ | PHENOBARBITAL | 1 | Oral | 150 MILLIGRAM(S); DAILY | U | UNKNOWN | 0 | 150 | MG | ||||||
| 126435181 | 12643518 | 6 | SS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MILLIGRAM(S); DAILY | U | UNKNOWN | 0 | 40 | MG | ||||||
| 126435181 | 12643518 | 7 | SS | ARIPIPRAZOLE. | ARIPIPRAZOLE | 1 | Oral | 10 MILLIGRAM(S); DAILY | U | UNKNOWN | 0 | 10 | MG | ||||||
| 126435181 | 12643518 | 8 | SS | LAROXYL | AMITRIPTYLINE | 1 | Oral | 75 MILLIGRAM(S); DAILY | U | UNKNOWN | 0 | 75 | MG | ||||||
| 126435181 | 12643518 | 9 | SS | TRAMADOL LP ZENTIVA | TRAMADOL HYDROCHLORIDE | 1 | Oral | 200 MILLIGRAM(S); TWICE A DAY | U | UNKNOWN | 0 | 200 | MG | ||||||
| 126435181 | 12643518 | 10 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK | U | UNKNOWN | 0 | ||||||||
| 126435181 | 12643518 | 11 | SS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MILLIGRAM(S); DAILY | U | UNKNOWN | 0 | 10 | MG | FILM-COATED TABLET | |||||
| 126435181 | 12643518 | 12 | SS | NUCTALON | ESTAZOLAM | 1 | Oral | 2 MILLIGRAM(S); DAILY | U | UNKNOWN | 0 | 2 | MG | ||||||
| 126435181 | 12643518 | 13 | SS | DIAZEPAM. | DIAZEPAM | 1 | Oral | 5 MG, QD | U | UNKNOWN | 0 | 5 | MG | ||||||
| 126435181 | 12643518 | 14 | SS | UROREC | SILODOSIN | 1 | Oral | 8 MILLIGRAM(S); DAILY | U | UNKNOWN | 0 | 8 | MG | CAPSULE | |||||
| 126435181 | 12643518 | 15 | SS | THERALENE | TRIMEPRAZINE | 1 | Oral | 15 MILLIGRAM(S); DAILY | U | UNKNOWN | 0 | 15 | MG | FILM-COATED TABLET | |||||
| 126435181 | 12643518 | 16 | SS | GLYCERYL TRINITRATE | NITROGLYCERIN | 1 | Cutaneous | 1 DOSAGE FORM; DAILY | U | UNKNOWN | 0 | 1 | DF | TRANSDERMAL PATCH | |||||
| 126435181 | 12643518 | 17 | SS | FORADIL | FORMOTEROL FUMARATE | 1 | UNK, INHALATIONAL | U | UNKNOWN | 0 | |||||||||
| 126435181 | 12643518 | 18 | SS | BISOCE | BISOPROLOL | 1 | Oral | UNK | U | UNKNOWN | 0 | FILM-COATED TABLET | |||||||
| 126435181 | 12643518 | 19 | SS | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | UNK, INHALATIONAL | U | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126435181 | 12643518 | 1 | Product used for unknown indication |
| 126435181 | 12643518 | 2 | Product used for unknown indication |
| 126435181 | 12643518 | 3 | Product used for unknown indication |
| 126435181 | 12643518 | 4 | Product used for unknown indication |
| 126435181 | 12643518 | 5 | Product used for unknown indication |
| 126435181 | 12643518 | 6 | Product used for unknown indication |
| 126435181 | 12643518 | 7 | Product used for unknown indication |
| 126435181 | 12643518 | 8 | Product used for unknown indication |
| 126435181 | 12643518 | 9 | Product used for unknown indication |
| 126435181 | 12643518 | 10 | Product used for unknown indication |
| 126435181 | 12643518 | 11 | Product used for unknown indication |
| 126435181 | 12643518 | 12 | Product used for unknown indication |
| 126435181 | 12643518 | 13 | Product used for unknown indication |
| 126435181 | 12643518 | 14 | Product used for unknown indication |
| 126435181 | 12643518 | 15 | Product used for unknown indication |
| 126435181 | 12643518 | 16 | Product used for unknown indication |
| 126435181 | 12643518 | 17 | Product used for unknown indication |
| 126435181 | 12643518 | 18 | Product used for unknown indication |
| 126435181 | 12643518 | 19 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126435181 | 12643518 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126435181 | 12643518 | Hyponatraemia | |
| 126435181 | 12643518 | Inappropriate antidiuretic hormone secretion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126435181 | 12643518 | 4 | 2015 | 0 | ||
| 126435181 | 12643518 | 10 | 2015 | 0 |